Vincerx Pharma, Inc. Proceeds from Warrant Exercises
Vincerx Pharma, Inc. reported Proceeds from Warrant Exercises of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2023-03-28
- Vincerx Pharma, Inc. proceeds from warrant exercises for the quarter ending 2022-12-31 was $0.00.
- Vincerx Pharma, Inc. proceeds from warrant exercises for the quarter ending 2022-09-30 was $0.00.
- Vincerx Pharma, Inc. proceeds from warrant exercises for the quarter ending 2021-12-31 was $0.00.
- Vincerx Pharma, Inc. proceeds from warrant exercises for the quarter ending 2021-09-30 was $0.00.
- Vincerx Pharma, Inc. proceeds from warrant exercises for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Vincerx Pharma, Inc. proceeds from warrant exercises for fiscal 2021 was $40.67M.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $32.49M derived: sum of 3 quarters · filed 2023-03-28 | $40.67M 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $32.49M derived: sum of 2 quarters · filed 2022-11-10 | $40.67M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $32.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $40.67M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $8.18M 10-Q · filed 2022-05-12 |